In this study, we evaluated the diagnostic potential and clinical impact of an automated multiplex PCR platform (the FilmArray Respiratory Panel; FA-RP), specially designed for pathogen detection in respiratory tract infections in adults with unexplained pneumonia (UP).
| INTRODUC TI ON
After the severe acute respiratory syndrome outbreak, in order to track similarly highly contagious and severe lower respiratory illness with pneumonia symptoms, the Chinese government has paid great attention to unexplained pneumonia (UP), a phrase coined by the Chinese Human Unexplained Pneumonia Surveillance Network (CHUPSN) and published in 2004. UP refers to pneumonia, which could be life-threatening, characterized by rapid progression, a normal white blood cell count range, and poor response to antibiotics. 1 Although the common pathogens causing UP are viruses or atypical pathogens, their overlapping clinical manifestations can impede the ability of clinicians to directly diagnose the causative pathogens, which may lead to unnecessary antimicrobial usage. Thus, rapid and precise diagnosis of the causative agents is critical for the prompt management of UP.
To date, culture-based and other traditional methods have been used to help the clinical approach to diagnose UP; however, these methods have certain disadvantages. For example, rapid antigen testing has only a 40%-100% sensitivity for adult influenza and is dependent on the use of specific scientific techniques, whereas culturing viruses can take up to 10 days. 2 In recent years, there has been an increase in the use of nucleic acid amplification test (NAAT)-based methods for the detection of viral pathogens due to their excellent diagnostic ability in identifying a broad spectrum of pathogens. 3 FilmArray multiplex PCR (BioFire Diagnostics, Inc, a bioMérieux Company) is a NAAT method that can be used to de- With the increasing implementation of the FA-RP in clinical microbiology laboratories, further studies are required to determine the clinical diagnostic ability of the method and its influence on patient outcomes and antimicrobial usage. Accordingly, in this study, we aimed to evaluate the clinical impact of FA-RP on UP patient treatment compared with conventional methods. To this end, we prospectively enrolled patients diagnosed with UP and analyzed the pathogen detection ability of the FA-RP. Moreover, we evaluated the clinical impact of FA-RP on patients based on a comparison of the clinical outcomes and medical records of the patient cohort enrolled during the period from October 2016 to March 2018 with the data of a cohort retrospectively collected for the period between October 2014 and March 2016. We aimed to evaluate the effect of using the FilmArray in terms of the quantification of antimicrobial use, use of antiviral drugs, and de-escalation or adjustment of antibiotic treatment.
| MATERIAL S AND ME THODS

| Study design and participants
The prospective cohort was enrolled in Shanghai, China, between October 2016 and March 2018, including two consecutive winter seasons. Eligible patients were recruited based on a modified definition of UP by CHUPSN as follows: (a) fever (>38°C); (b) pneumonia radiographic results; (c) normal or slightly decreased number of total white blood cells in the early stage of the disease; (d) duration of illness of ≤14 days; (e) poor response to initial antibiotic treatment; and (f) a minimum age of 18 years old. Samples from all enrolled patients were submitted to FA-RP analyses and were accordingly referred to as the "FA-RP group." We recorded the demographic characteristics of patients and their relevant clinical data. Patients in the FA-RP group who were not lost to follow-up and had complete data were referred to as the "intervention group."
A historical control cohort was retrospectively recruited using the same inclusion criteria among patients who were hospitalized between October 2014 and March 2016, during which time the FA-RP was not available. Similar to the FA-RP group, relevant data of the patients within the control cohort were recorded. ing, whereas viscous samples, such as sputum, were pre-treated using the previously described dunk and swirl method. 5 The remaining specimens were stored in a −80°C freezer for further use.
| Sampling
| The FilmArray respiratory panel
In this study, we used version 1.7 of the FA-RP. It is an automated multiplex PCR detection platform designed to detect 20 common pathogens causing respiratory infection and has a single specimen turnaround time of <2 hours. Tests using the panel were performed following the manufacturer's instructions.
| Real-time RT-PCR
For specimens that the FA-RP reported as "Influenza A, not sub- 
| Traditional laboratory tests
For both patient groups, traditional standard-of-care laboratory diagnostic tests for respiratory infections were performed according to the requests of physicians, including smears, cultures, and serological tests. The serological test in our study was the PNEUMOSLIDE IgM (Vircell) commercial kit based on indirect immunofluorescence.
| Evaluation of clinical antimicrobial use
In this study, clinical data, including antimicrobial use, and adjustment or de-escalation of antimicrobial therapy, were compared between the FA-RP group and retrospective control group. Turnaround time was defined as the length of time from sample collection to receiving the FA-RP results. Antimicrobial use was quantified as the defined daily dose (DDD)) number, calculated as ∑ (Drug Total Dosage (g)/Drug DDD index). 6 Adjustment of antimicrobial therapy was defined as a change in antimicrobial regimen immediately after receiving the FA-RP results.
F I G U R E 1 Overview of Patient
Enrollment Workflow. A total of 112 patients selected prospectively were submitted to FA-RP analyses and are referred to as the "FA-RP group." Those who were not lost to follow-up and had complete data are referred to as the "intervention group." Comparison was made between it and the historical control group
| Statistical analysis and ethics approval
The Mann-Whitney U test was used for the comparison of quantitative data. spss 20.0 (IBM) was used for data analyses. We used Graphpad 6.0 for drawing graphs. The Ethics Committee of the Huashan Hospital, Shanghai, approved the study (KY2013-251; July 2, 2013). All participants gave their written informed consent. Table 1 . Mixed infections of multiple pathogens were detected in six patients: Influenza virus/RSV (n = 1), Influenza virus/human metapneumovirus (n = 1), Influenza virus/parainfluenza-2 (n = 1), M pneumoniae/human rhinovirus/enterovirus (n = 1), human rhinovirus/ enterovirus/parainfluenza-2 (n = 1), and adenovirus/coronavirus HKU1/coronavirus OC43 (n = 1). For 13 samples, the FA-RP results were "Influenza A/not subtyped." In these cases, further subtyping was performed using real-time RT-PCR. As a consequence, Influenza A virus subtype H7N9 was detected in 11 samples and H1N1-2009 in the remaining two samples. As a consequence of the findings of the FA-FP regarding Influenza A, 15 patients were isolated in a negative pressure ward or single ward, including seven highly pathogenic H7N9 cases. In contrast, in the control group, no comparable isolation measures were undertaken.
| RE SULTS
| Population characteristics
| Summary of pathogens detected in prospective group patients using the FA-RP
| Impact on treatment decisions compared with the control group
When we compared antimicrobial use between the intervention and control groups, we found that the two groups were comparable for the most baseline characteristics ( Table 4 ).
| D ISCUSS I ON
In this study, we applied FA-RP on diagnosis of UP, which is a certain type of pneumonia causing mainly by viruses and atypical pathogens.
We found that the FA-RP detected pathogens in 76.8% (86/112) of all specimens, which is higher than that the detection rate obtained when this technique was applied for general community-acquired pneumonia (38.6%, 49/127). 7 These results, therefore, show that when applied clinically for UP, the FA-RP would provide a higher probability of identifying causal pathogenic microorganisms.
The findings of the present study also confirmed that sputum and BALF could be used as samples for FA-RP tests, which contrasts with the manufacture's assertion that NPS stored in viral transport media (VTM) is the only suitable material that is compatible. Indeed, we obtained positive FA-RP results for all the types of respiratory tract specimens. Notably, however, when performing this test, pre-treatment of specimens with high viscosity, such as sputum, is essential; otherwise, the reactions are likely to fail. Here, we pretreated samples following the procedure described by Branche, 5 using a clean swab to stir the sputum and then placing it into VTM, so that the pathogens were transferred into a low viscosity medium that is suitable for the FA-RP. Previous studies have reported that lower respiratory tract specimens should be accorded higher sampling priority (ie BALF > sputum > NPS), and have indicated that the performance of the FA-RP in patients with pneumonia could be improved by using BALF. [8] [9] [10] Consistently, in the present study, we obtained higher positive rates when using BALF and sputum samples than when using NPS, although the difference was not significant (78.8% vs 61.5%, P = .166). Moreover, in recent years, saliva has also shown potential as a suitable material for the molecular detection of respiratory viruses. 11 We prospectively enrolled patients diagnosed with UP during the period from October 2016 to March 2018, and attempted to identify the causal pathogens. We accordingly found that Influenza When specimens were positive for Influenza A viruses other than H1, H1-2009, and H3, FA-RP reported as "not subtyped." c Extra microbiological investigations, including smear, culture, or serology, were done for negative specimens. Pneumocystis jiroveci (n = 1), Aspergillus spp. (n = 1), Mycoplasma pneumonia (n = 1), Mycobacterium tuberculosis (n = 1), mixed infection with Enterobacter cloacae, and Candida tropicalis (n = 1) were confirmed.
of the FA-RP may be of particular benefit with respect to the clinical management of pneumonia of unknown cause.
In the present study, we found that 53.8% (60/112) of the patients in the FA-RP group received antiviral treatment, which is significantly higher than that in the control group (14.3%, 10/70; P < .001). Among those patients who received a positive test result for the Influenza virus, 100% (43/43) were treated with oseltamivir that is notably higher than the 74%-81% reported in other studies carried out in the United States. 15, 16 Moreover, adjustment of antibiotic therapy was reported for 69.6% (78/112) of the patients in the FA-RP group, compared with only 5.1% (4/79) in the control group.
These findings strongly indicate that the results of the FA-RP test may assist in clinical decision making, particularly with respect to reducing unnecessary antibiotic usage in the treatment of UP.
The rapid identification of pathogens causing respiratory tract infection has both essential clinical and public health values. In the present study, 15 of the enrolled patients were promptly isolated as soon as the diagnosis of Influenza virus infection had been established. In contrast, for the control group patients who did not receive precise diagnosis of causing agents, no comparable isolation measures were undertaken. Such a lack of an accurate diagnosis may lead to a delay in patient isolation and, consequently, the wider spread of viruses. Moreover, for these patients, we consciously sought to regularly analyze the viral nucleic acids in the patient's respiratory specimens using real-time PCR, and patients were discharged only after the nucleic acid test proved negative, thereby reducing the risk of the disease spreading.
To further evaluate the clinical impact of the FA-RP, we compared the antibiotic use of adult UP patients in the FA-RP cohort and the historical control cohort, the latter of which were diagnosed only by using conventional methods. We found that compared with the control cohort, the intervention group had significantly lower antimicrobial DDDs, particularly with respect to the use of antibiotics and antifungal drugs. These results thus serve to highlight that given the benefit of an accurate diagnosis of the etiology, a more reasonable antibiotic usage could be achieved. These results are partially consistent with the findings of some previously published studies. randomized controlled trial discovered that use of the FA-RP was not associated with a reduction in the overall duration of antibiotic usage. 18 Nevertheless, a higher number of patients in the FA-RP group received single doses or brief courses of antibiotics than those in the control group. Given these inconclusive findings, further studies are required concerning the impact of FA-RP on the clinical decisions regarding pneumonia.
We compared the duration of hospital stay between the two groups. As a result, intervention group unexpectedly showed longer duration of hospital stay than the control group (12.1 vs 7.6 days, P = .001). One reasonable explanation is that subjects in the intervention group had more severe cases of pneumonia than those in the control group (higher PSI, This present study is one of the several that have examined the application of FA-RP in Asia. [19] [20] [21] [22] [23] [24] Compared with other published studies, our study focused on adults with more severe pneumonia conditions, and to the best of our knowledge, it is the only study that Our study does, however, have a few limitations. Notably, the sample size was limited, and the study was conducted only at a single location, which may thus limit the general applicability of the findings. In addition, the study included two cohorts from different time periods; hence, there may have been differences in factors that influenced clinician behavior between the two periods that were not accounted in our analysis. Furthermore, the incidence of various respiratory viruses may have varied across the two periods that may thus limit the validity of a direct comparison of clinical outcomes.
In conclusion, the FA-RP is a rapid and sensitive NAAT method that can be used for the diagnosis of UP in adults. In the two recent years in Shanghai, the most common pathogen causing UP was identified as the Influenza virus. However, in this regard, it should be taken into consideration that the current version of the FA-RP is unable to directly detect H7N9. Nevertheless, the results obtained in this study show that the FA-RP may make a valuable contribution to clinical decision making and facilitate the reasonable use of antibiotics.
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